iBio (IBIO) Research & Development (2010 - 2026)

iBio (IBIO) has 17 years of Research & Development data on file, last reported at $3.3 million in Q1 2026.

• On a quarterly basis, Research & Development rose 70.72% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $14.3 million, a 129.74% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 60.31% from the prior year.
• Research & Development for Q1 2026 stood at $3.3 million, down from $4.3 million in the prior quarter.
• Over the last five years, Research & Development for IBIO reached as high as $4.3 million in Q4 2025 and fell as low as $904000.0 in Q1 2024.
• Historically, Research & Development has averaged $2.5 million across 5 years, with a median of $2.6 million in 2022.
• Across the five-year window, Research & Development tumbled 71.94% in 2024 and surged 182.81% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.8 million in 2022, then sank by 44.76% to $1.5 million in 2023, then rose by 22.28% to $1.9 million in 2024, then surged by 128.02% to $4.3 million in 2025, then slipped by 23.97% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $3.3 million in Q1 2026, $4.3 million in Q4 2025, and $3.6 million in Q3 2025.